New Cholesterol Drug Could Cut Strokes and Heart Attacks in Half

September 1, 2014 3:13 AM

16 0

By Emma Harrison Clark, September 1st, 2014 | No Comments

Good news has come to light for patients in the battle against cholesterol. An experimental trial by Sanofi and Regeneron Pharmaceuticals has proven to cut the number of heart attacks and strokes almost in half. The clinical trial was analysed retrospectively, which means the results are not yet con...

Also read: FDA Approves First Nonopioid Treatment for Opioid Withdrawal Symptoms

Read more

To category page